4.2 Article

Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer

期刊

PROSTATE INTERNATIONAL
卷 9, 期 2, 页码 107-112

出版社

ELSEVIER INC
DOI: 10.1016/j.prnil.2020.07.008

关键词

Prostatic neoplasms; Positron-emission tomography; Observational study

向作者/读者索取更多资源

The sensitivity of PSMA PET/CT for detecting RP-confirmed prostate cancer was 81.2%. Patient age and clinical T stage strongly correlated with focal intraprostatic PSMA PET/CT uptake. The ISUP grade group from final RP was predicted by SUVmax, PSA, and the maximal dimension of PET-avid lesions.
Background: We aimed to evaluate the utility of prostate-specific membrane antigen (PSMA) PET/CT for the detection of local disease within the prostate. Methods: This is a retrospective review of a single-center experience evaluating intraprostatic detection rates compared with final histopathology in a radical prostatectomy (RP) population. Seventy-two patients had PSMA PET/CT scan performed as part of their primary staging. Intraprostatic PSMA PET/CT avidity was assessed. PSMA PET/CT uptake was retrospectively correlated with patient characteristics including final histopathology, MRI Prostate Imaging Reporting and Data System (PI-RADS) score, clinical tumor stage, prostate-specific antigen (PSA) level, and patient age. Results: The sensitivity of PSMA PET/CT for the detection of RP-confirmed prostate cancer was 81.2%. Much higher sensitivity was found within certain subpopulations. The patient characteristics that most strongly correlated with focal intraprostatic PSMA PET/CT uptake were patient age (Kendall's tau coefficient tau(b) = 0.24, p < 0.05) and clinical T stage (tau(b) = 0.21, p < 0.05). The International Society of Urological Pathology (ISUP) grade group from final RP was predicted by standardized uptake value (SUVmax) and to a lesser extent PSA and the maximal dimension of PET-avid lesions. SUVmax monotonically increased with ISUP grade group. If SUVmax was above 10 g/mL, the final RP histopathology had a relative risk of 2.3 (95% CI 1.3-4.1) of being ISUP grade group 5. Conclusion: This trial provides early evidence that PSMA PET/CT assists in the grading of prostate cancer and suggests that the imaging modality is particularly accurate in subpopulations including the elderly and those with palpable disease. (C) 2021 Asian Pacific Prostate Society. Published services by Elsevier B.V.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据